UBS Group AG - QUOIN PHARMACEUTICALS LTD ownership

QUOIN PHARMACEUTICALS LTD's ticker is and the CUSIP is 74907L201. A total of 8 filers reported holding QUOIN PHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of QUOIN PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2023$3,121
-87.0%
6,556
-37.9%
0.00%
Q3 2022$24,00010,5580.00%
Other shareholders
QUOIN PHARMACEUTICALS LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 36,630$82,0000.23%
Virtu Financial LLC 29,865$67,0000.01%
UBS Group AG 10,558$24,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 79$00.00%
Citadel Advisors 17,614$39,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 15,366$34,0000.00%
JANE STREET GROUP, LLC 11,609$26,0000.00%
View complete list of QUOIN PHARMACEUTICALS LTD shareholders